查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1879874

全球血管成形術用氣球市場

Angioplasty Balloons
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球血管成形術用氣球市場預計2030年將達38億美元。

全球血管成形球囊市場規模在2024年估計為30億美元，預計到2030年將達到38億美元，在分析期（2024-2030年）內複合年成長率（CAGR）為3.9%。本報告分析的細分市場之一－一般氣球，預計複合年成長率為3.9%，到分析期末將達到21億美元。藥物塗層球囊細分市場預計在分析期間內複合年成長率為4.1%。

美國市場規模估計為7.933億美元，而中國市場預計將以5.9%的複合年成長率成長。

據估計，2024年美國血管成形球囊市場規模將達7.933億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到7.876億美元，在2024年至2030年的分析期內，複合年成長率（CAGR）為5.9%。其他值得關注的區域市場分析包括日本和加拿大，預計在分析期間內，這兩個國家的複合年成長率分別為2.6%和3.0%。在歐洲，德國預計將以約3.1%的複合年成長率成長。

全球血管成形球囊市場－主要趨勢與促進因素概述

血管成形術球囊如何革新心臟照護？

血管成形球囊是介入性心臟病學領域的重要工具，在冠狀動脈疾病（CAD）的治療中發揮關鍵作用。這些裝置用於經經皮冠狀動脈介入治療（PCI）中，以擴張狹窄或阻塞的冠狀動脈，恢復心肌的血液供應，並緩解胸痛和呼吸困難等症狀。手術過程中，將一根頂端帶有未充氣球囊的導管插入病變動脈。指定，球囊充氣，將斑塊壓向動脈壁，進而擴張血管。血管成形術用氣球的引入徹底改變了心臟治療，為冠狀動脈繞道手術手術（CABG）提供了微創替代方案，並縮短了患者的復健時間和住院時間。

哪些創新使血管成形術球囊更有效？

技術進步顯著提高了血管成形術用氣球的療效和安全性。藥物釋放型球囊（DEB）的研發是一項突破性創新，它將機械性斑塊壓迫與局部藥物輸送相結合，以預防再血管再阻塞（動脈血管再阻塞）。這些球囊表面塗覆抗增生藥物，充氣後藥物會釋放到動脈壁內，抑制可能導致血管再阻塞的疤痕組織生長。此外，具有微型刀片或刻痕元件的切割球囊和球囊導管的引入，並改進了斑塊可控切開技術，特別適用於處理硬化或鈣化病變。這些進步不僅提高了血管成形術的成功率，也減少了再次介入的需求，並改善了患者的長期預後。

為什麼以病人為中心的照護在血管成形術用氣球應用中如此重要？

以病人為中心的照護是血管成形術用氣球推廣和成功的關鍵因素。隨著個人化醫療的日益普及，醫療服務提供者致力於根據每位患者的需求和病情量身定做治療方法。這種方法包括仔細評估患者的個別因素，例如動脈阻塞的嚴重程度和位置、患者的整體狀況以及合併症。先進的影像和診斷工具能夠實現血管成形術的精確規劃和實施，確保球囊的最佳選擇和放置。此外，病患教育和術後護理在改善治療效果方面也發揮著至關重要的作用。充分了解自身病情的患者更有可能堅持服用處方藥物並做出必要的健康生活方式改變，從而維護動脈健康。這種以患者為中心的綜合性心臟護理模式不僅能夠改善臨床療效，還有助於提高患者的滿意度和生活品質。

哪些因素正在推動血管成形術用氣球市場的成長？

血管成形術用氣球市場的成長受多種因素驅動，包括技術進步、終端應用以及不斷發展的醫療實踐。心血管疾病，尤其是冠狀動脈疾病（CAD）的日益普及是主要促進因素，由於人口老化和生活方式相關的風險因素，全球CAD負擔持續加重。藥物釋放型球囊和切割/球囊導管等技術創新透過提高手術效率和改善患者預後，推動了市場成長。導管技術和影像技術的進步，促進了微創治療的普及，並擴大了血管成形術用氣球在不同患者群體中的應用。此外，對預防保健和早期診斷的日益重視，也促使血管成形術更頻繁地作為冠狀動脈疾病（CAD）的第一線治療方法。新興市場醫療基礎設施的不斷改進和醫療費用支出的成長，也促進了市場成長，使更多患者能夠獲得先進的心臟治療技術。此外，對個人化醫療和以患者為中心的護理模式的關注，正在推動對客製化血管成形術解決方案的需求，進一步加速市場擴張。

部分：

依產品類型（一般氣球、藥物釋放型球囊、其他產品）、應用（冠狀動脈成形術、周邊血管成形術）及最終用途（醫院、門診手術中心、其他最終用途）進行分類。

受訪公司範例

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE &Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endocor GmbH
  • Medtronic PLC
  • Terumo Corporation
  • The Spectranetics Corporation

人工智慧整合

我們正在利用檢驗的專家內容和人工智慧工具，革新市場和競爭情報分析。

Market Glass, Inc. 並沒有採用查詢LLM 或產業專用的SLM 的典型方法，而是建立了一個由世界各地領域專家精心策劃的內容庫，其中包括影片轉錄、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

在最新發布的報告中，Market Glass, Inc. 將關稅對地理市場的影響納入考量，並根據公司總部所在地、製造地以及進出口（成品和OEM產品）情況，預測企業競爭地位的變化。這種複雜多變的市場現實會從多個方面影響競爭對手，包括增加銷貨成本、降低盈利和重組供應鏈，同時也會影響微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 亞太其他地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP10289

Global Angioplasty Balloons Market to Reach US$3.8 Billion by 2030

The global market for Angioplasty Balloons estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Normal Balloons, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Drug-Coated Balloons segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$793.3 Million While China is Forecast to Grow at 5.9% CAGR

The Angioplasty Balloons market in the U.S. is estimated at US$793.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$787.6 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Global Angioplasty Balloons Market - Key Trends and Drivers Summarized

How Are Angioplasty Balloons Revolutionizing Cardiac Care?

Angioplasty balloons are integral tools in the field of interventional cardiology, playing a pivotal role in the treatment of coronary artery disease (CAD). These devices are used in percutaneous coronary interventions (PCI) to dilate narrowed or blocked coronary arteries, restoring blood flow to the heart muscle and alleviating symptoms such as chest pain and shortness of breath. The procedure involves inserting a catheter with a deflated balloon at its tip into the affected artery. Once positioned, the balloon is inflated to compress the plaque against the artery walls, thereby widening the vessel. The advent of angioplasty balloons has revolutionized cardiac care by offering a minimally invasive alternative to coronary artery bypass grafting (CABG), reducing recovery times and hospital stays for patients.

What Technological Innovations Are Enhancing the Efficacy of Angioplasty Balloons?

Technological advancements have significantly enhanced the efficacy and safety of angioplasty balloons. The development of drug-eluting balloons (DEBs) represents a major innovation, combining mechanical plaque compression with localized drug delivery to prevent restenosis, or re-narrowing of the artery. These balloons are coated with antiproliferative drugs, which are released into the arterial wall during inflation, inhibiting the growth of scar tissue that can lead to restenosis. Additionally, the introduction of cutting and scoring balloons, equipped with tiny blades or scoring elements, provides an improved method for tackling particularly tough or calcified lesions by creating controlled incisions in the plaque. These advancements not only improve the success rates of angioplasty procedures but also reduce the need for repeat interventions, enhancing long-term patient outcomes.

Why Is Patient-Centric Care Vital in the Adoption of Angioplasty Balloons?

Patient-centric care is a critical factor in the adoption and success of angioplasty balloon procedures. With a growing emphasis on personalized medicine, healthcare providers are increasingly focusing on tailoring treatments to individual patient needs and conditions. This approach involves careful assessment of patient-specific factors such as the severity and location of arterial blockages, overall health, and coexisting medical conditions. Enhanced imaging techniques and diagnostic tools enable precise planning and execution of angioplasty procedures, ensuring optimal balloon selection and placement. Moreover, patient education and post-procedural care play a vital role in improving outcomes, as informed patients are more likely to adhere to prescribed medications and lifestyle modifications necessary to maintain artery health. The shift towards a holistic, patient-centric approach in cardiac care not only improves clinical outcomes but also enhances patient satisfaction and quality of life.

What Factors Are Driving Growth in the Angioplasty Balloons Market?

The growth in the angioplasty balloons market is driven by several factors related to technological advancements, end-use applications, and evolving healthcare practices. The increasing prevalence of cardiovascular diseases, particularly coronary artery disease, is a major driver, as the global burden of CAD continues to rise with aging populations and lifestyle-related risk factors. Technological innovations, such as drug-eluting balloons and cutting/scoring balloons, are propelling market growth by improving procedural efficacy and patient outcomes. The shift towards minimally invasive procedures, supported by advancements in catheter-based technologies and imaging modalities, is expanding the use of angioplasty balloons in diverse patient populations. Additionally, the growing emphasis on preventive healthcare and early diagnosis is leading to more frequent use of angioplasty as a first-line treatment for CAD. The expansion of healthcare infrastructure in emerging markets and increased healthcare expenditure are also contributing to market growth, providing greater access to advanced cardiac care technologies. Moreover, the focus on personalized medicine and patient-centric care models is driving demand for tailored angioplasty solutions, further accelerating market expansion.

SCOPE OF STUDY:

The report analyzes the Angioplasty Balloons market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Normal Balloons, Drug-Coated Balloons, Other Products); Application (Coronary Angioplasty, Peripheral Angioplasty); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endocor GmbH
  • Medtronic PLC
  • Terumo Corporation
  • The Spectranetics Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Angioplasty Balloons - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Throws the Spotlight on Angioplasty Balloons
    • Technological Innovations in Drug-Eluting Balloons Propel Growth in the Market
    • Advances in Cutting and Scoring Balloons Expand Addressable Market Opportunity
    • Aging Population and Lifestyle-Related Risk Factors Drive Demand for Angioplasty Solutions
    • Minimally Invasive Procedures Trend Strengthens Business Case for Angioplasty Balloons
    • Integration of Advanced Imaging Techniques Generates Demand for Precision Angioplasty
    • Development of Portable and User-Friendly Devices Propels Adoption in Diverse Settings
    • Focus on Reducing Restenosis Rates Strengthens Business Case for Advanced Balloons
    • Integration of Digital Health and Remote Monitoring Generates New Market Opportunities
    • Trends in Outpatient Cardiac Care Propel Demand for Efficient Angioplasty Solutions
    • Investment in Innovative Catheter-Based Technologies Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Angioplasty Balloons Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Normal Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Normal Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Normal Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug-Coated Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Drug-Coated Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Drug-Coated Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Coronary Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Coronary Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Coronary Angioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Peripheral Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Peripheral Angioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • JAPAN
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • CHINA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • EUROPE
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Angioplasty Balloons by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • FRANCE
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • GERMANY
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Angioplasty Balloons by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • INDIA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Angioplasty Balloons by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Angioplasty Balloons by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030
  • AFRICA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2015, 2025 & 2030

IV. COMPETITION